We are live on
!
Find out more
JIC
Joel Isaacson & Co Portfolio holdings
AUM
$3.02B
1-Year Est. Return
21.81%
This Fund
S&P 500
This Quarter
Est. Return
+7.77%
1 Year Est. Return
+21.81%
3 Year Est. Return
+61.27%
5 Year Est. Return
+65.83%
10 Year Est. Return
+229.48%
AUM
$769M
AUM Growth
+$67.1M
(+9.6%)
Cap. Flow
+$16.1M
Cap. Flow
% of AUM
2.09%
Top 10 Holdings %
Top 10 Hldgs %
65.93%
Holding
233
New
21
Increased
85
Reduced
38
Closed
5
Top Buys
| 1 |
Match Group
MTCH
|
+$8.01M |
| 2 |
Vanguard Dividend Appreciation ETF
VIG
|
+$3.35M |
| 3 |
Vanguard S&P 500 Growth ETF
VOOG
|
+$2.44M |
| 4 |
Vanguard Small-Cap ETF
VB
|
+$1.49M |
| 5 |
Vanguard Total Stock Market ETF
VTI
|
+$1.39M |
Top Sells
| 1 |
PPLI
People Inc
PPLI
|
+$9.04M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$634K |
| 3 |
State Street SPDR S&P Dividend ETF
SDY
|
+$468K |
| 4 |
iShares Select Dividend ETF
DVY
|
+$322K |
| 5 |
RVLP
RVL Pharmaceuticals plc Ordinary Shares
RVLP
|
+$303K |
Sector Composition
| 1 | Technology | 8.68% |
| 2 | Communication Services | 7.11% |
| 3 | Consumer Staples | 3.85% |
| 4 | Healthcare | 3.24% |
| 5 | Financials | 3.03% |
Similar funds
CFM
SM
TAM
KIA
CI
CM
BGDI
Joel Isaacson & Co's Q3 2020 Portfolio in Review
As of Q3 2020, Joel Isaacson & Co held 233 positions worth $769M, up 9.6% from $702M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Joel Isaacson & Co's Q3 2020 filing shows 21 new, 85 increased, 38 reduced and 5 closed positions. Its largest new stake was Match Group: 75,614 shares worth $8.37M. The largest sale was People Inc, an estimated $9.04M.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 8% a quarter earlier, followed by Communication Services and Consumer Staples.
- Joel Isaacson & Co's largest Q3 2020 buy was Match Group: 75,614 shares worth $8.37M.
- Joel Isaacson & Co added most to Vanguard Dividend Appreciation ETF in Q3 2020, an estimated $3.35M increase.
- Joel Isaacson & Co's biggest Q3 2020 reduction was People Inc, cutting an estimated $9.04M.
- Joel Isaacson & Co fully exited RVL Pharmaceuticals plc Ordinary Shares in Q3 2020, selling an estimated $303K.
- Joel Isaacson & Co's ten largest holdings make up 66% of its $769M portfolio in Q3 2020.
- Joel Isaacson & Co opened 21 new positions and closed 5 in Q3 2020.
- Joel Isaacson & Co's portfolio value rose 9.6% quarter-over-quarter to $769M.
Based on Joel Isaacson & Co's 13F filing for Q3 2020, filed 14 Oct 2020.